Establishment of an N-Glycan Profiling Method for Three ERT Enzymes Used in Gaucher Disease Therapy. [PDF]
Chen J +6 more
europepmc +1 more source
From Lysosomal Storage to Neurodegeneration: Sphingolipid Signaling as a Driver of CNS Pathology and Biomarker Strategy in Neuronopathic Gaucher Disease. [PDF]
Casazza K, Kartha RV, Jarnes JR.
europepmc +1 more source
Gaucher Disease-Correlation of Lyso-Gb1 with Haematology and Biochemical Parameters. [PDF]
D'Amore S +3 more
europepmc +1 more source
Family studies in Gaucher Disease: a key resource for early diagnosis and personalized treatment strategies. [PDF]
Vinci M +12 more
europepmc +1 more source
Exploring delayed diagnosis in Gaucher disease: insights from a community survey and potential solutions. [PDF]
Aragón DPP +6 more
europepmc +1 more source
The c-Abl-RIPK3 Axis Drives Mitochondrial Dysfunction and Impaired Mitophagy in Gaucher Disease Models. [PDF]
Lamaizon CM +8 more
europepmc +1 more source
Phenotypic Spectrum of Type 2-3 Gaucher Disease: A Case Study in the Balkan Genotype. [PDF]
Cullufi P +8 more
europepmc +1 more source
Patient-specific midbrain organoids with CRISPR correction recapitulate neuronopathic Gaucher disease phenotypes and enable evaluation of novel therapies. [PDF]
Lin Y +15 more
europepmc +1 more source
Case Report: Progressive myoclonus epilepsy as an early manifestation of neuronopathic Gaucher disease. [PDF]
Fang Z +5 more
europepmc +1 more source
Diagnosis and follow-up of the first case of Gaucher disease under enzyme replacement therapy in Senegal. [PDF]
Keita M +7 more
europepmc +1 more source

